STOCK TITAN

Nurix Therapeutics officer proposes $263K share sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Nurix Therapeutics, Inc. officer Christine Ring reported a proposed sale of 11,008 common shares, with an aggregate market value of $263,201.28 and an approximate sale date of July 2, 2026. The reported common shares outstanding were 103,405,813. Ring acquired 11,008 shares on July 2, 2026, through exercise of stock options, with cash listed as the payment method. The reported plan adoption or instruction date is November 10, 2025.

Proposed sale 11,008 common shares Approximate sale date July 2, 2026
Aggregate market value $263,201.28 Proposed sale of common shares
Common shares outstanding 103,405,813 shares Outstanding share count reported with the proposed sale
Prior sale 28,935 common shares June 25, 2026; gross proceeds of $580,506.12
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Exercise of Stock Options financial
"Nature of Acquisition Transaction: Exercise of Stock Options"
Gross Proceeds financial
"Amount of Securities Sold | Gross Proceeds"
The total amount of cash a company receives from a financing event or sale before any fees, expenses, taxes or deductions are taken out. Investors watch gross proceeds because it shows the raw scale of new capital being raised—think of it as the paycheck amount before withholdings—which helps assess how much funding is available for operations, growth, debt payoff or how much shareholder dilution might occur once costs are removed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What prior NRIX sales did Christine Ring report?

The past-three-months table labels as 10b5-1 sales: 28,935 shares for $580,506.12 on June 25, 2026; 8,148 for $135,252.73 on June 2, 2026; 3,368 for $57,118.25 and 4,780 for $81,091.74 on May 4, 2026; and 5,394 for $90,406.68 on May 1, 2026. It also lists 3,214 shares for $53,497.99 on April 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading